HSBC Malta Funds SICAV announced Lisa Vella’s appointment to the Board of Directors of the company as Director with effect from 12th January 2022.
Ms Vella’s appointment is set to last up until the company’s forthcoming Annual General Meeting.
Following this appointment, the HSBC Malta Funds SICAV Board of Directors is composed of the following: Steven Tedesco, Richard Bernard, and Lisa Vella.
In her latest position, Ms Vella succeeds Konrad Borg Myatt, who resigned from his post as Director of the Company on 12th January.
The newly appointed Director also serves as CEO at HSBC Global Asset Management and as a Lecturer at the Institute of Financial Services and at the University of Malta.
For companies supplying Malta’s healthcare market, access to new manufacturers and technologies can shape their next phase of growth.
Jake Schembri says he will focus on bringing Merqury's technology into more deployments.
He brings extensive experience in energy policy, strategic planning and the development of national energy frameworks.
Vantive Health is a global healthcare compnay focused on providing therapies for patients with acute and chronic organ conditions.